IOTOD 2020

The 18th annual ‘Improving Outcomes in the Treatment of Opioid Dependence’ (IOTOD) meeting took place as a virtual event on the 24–25 September 2020.

The 2020 IOTOD Scientific Committee led an engaging two-day meeting, featuring international field experts speaking on multiple and emerging topics, such as: opioid analgesic dependence (OAD) and chronic pain; opioid substitution therapy adherence and the real significance; destigmatising drug use in key populations; the experience so far with long-acting buprenorphine formulations (and their use during COVID-19); different stakeholder perspectives surrounding drug use; and best approaches to address HCV/HBV in PWIDs. The webcasts from this conference will be available to view on the IOTOD 2021 conference platform once you have registered for the event.


Professor Catriona Matheson

Professor in Substance Use, University of Stirling

Stirling, UK

Professor Gabriele Fischer

Addictions Clinic Medical Director, Medical University of Vienna

Vienna, Austria

Professor Nicholas Lintzeris

Director, Drug and Alcohol Services, South East Sydney Local Health District

Sydney, Australia

Professor John Strang

Director, National Addiction Centre, King's College London

London, UK

Dr Jane Quinlan

Oxford University Hospitals Trust

Oxford, UK

Professor Heino Stöver

Professor of Social Scientific Addiction Research, Frankfurt University of Applied Sciences

Frankfurt, Germany

Mr Mat Southwell

European Network of People who Use Drugs (EuroNPUD)

Bath, UK

Dr Stephan Walcher

Director, Concept Centre for Addiction Medicine

Munich, Germany

Dr Arun Bhaskar

Hon Consultant, Pain Management Centre, Charing Cross Hospital, Imperial College NHS Trust

London, UK

Dr Michael Kelleher

Consultant Addictions Psychiatrist, South London and Maudsley NHS Foundation Trust

London, UK

Mr Duncan Hill

Specialist Pharmacist in Substance Misuse, NHS Lanarkshire

Glasgow, Scotland

Dr Jeremy Hayllar

Clinical Director, Alcohol and Drug Service, Metro North Mental Health


Professor Graham Foster

Professor of Hepatology, Queen Mary's University of London & Consultant, Bart's Health NHS Trust

London, UK

Professor Ashley Brown

Consultant Hepatologist, St. Mary’s and Hammersmith Hospitals, and Professor of Practice (Viral Hepatitis), Imperial College London

London, UK


The 2020 IOTOD conference is supported by the following companies:


Gilead Sciences


Session Sponsors



Manoeuvres in the fog: drug-drug interactions in OST
Practicalities of transitioning between opioid agonist treatments
New horizons for treatment: translating the latest research into clinical practice
Tailoring behavioural interventions: emerging evidence and practical implications
View all webcasts